Table 3. Distribution of Co-Infections (n = 215).
Dual Infections (n=163) | n | n | |
---|---|---|---|
IFV-A + HBoV | 26 | PIV + HCoV | 3 |
IFV-A + IFV-B | 20 | IFV-B + HCoV | 3 |
IFV-A + AdV | 13 | RSV A/B + PIV | 2 |
IFV-B + MP | 13 | IFV-A + PIV | 2 |
IFV-B + RV/EV | 12 | RV/EV + PIV | 2 |
RV/EV + AdV | 12 | RSV A/B + HCoV | 2 |
IFV-B + RSV A/B | 10 | IFV-A + LP | 1 |
RV/EV + HMPV | 9 | IFV-A + BP | 1 |
IFV-A + RSV A/B | 5 | IFV-A + MP | 1 |
HBoV + RSV A/B | 4 | IFV-A + RV/EV | 1 |
HBoV + MP | 4 | RSV A/B + CP | 1 |
IFV-A + HCoV | 4 | RV/EV + HBoV | 1 |
IFV-B + PIV | 3 | RV/EV + MP | 1 |
PIV + MP | 3 | HMPV + HBoV | 1 |
RSV A/B + LP | 3 | ||
Triple infections (n = 49) | n | n | |
IFV-A + HBoV + MP | 8 | IFV-B + AdV + HCoV | 5 |
IFV-B + RV/EV+ HCoV | 8 | RV/EV + HMPV + HBoV | 4 |
RV/EV + AdV + HBoV | 6 | RV/EV + AdV + HMPV | 4 |
RV/EV + HMPV + PIV | 5 | IFV-A + HBoV + HCoV | 4 |
AdV + HCoV + BP | 5 | ||
Quadruple infections (n = 3) | n | n | |
IFV-B + RV/EV + PIV+ MP | 1 | RV/EV + AdV + HBoV + HCoV | 1 |
RV/EV + RSV A/B + HCoV + MP | 1 |